Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Abivax (France) | Researchclopedia

Back to institutions

Abivax (France)

Pariscompany

91

Works

4,591

Citations

40

h-index

Top Research Topics

Inflammatory Bowel Disease Microscopic Colitis MicroRNA in disease regulation

Top Researchers

Jason P. Fine University of North Carolina at Chapel Hill

410 works34,667 citationsh-index: 67

Recent Research

DOP057 Obefazimod induction therapy for moderately to severely active ulcerative colitis: pooled analysis of inflammatory biomarkers from the two ABTECT Phase 3 double-blind, placebo-controlled induction trials

Britta Siegmund,Raja Atreya,et al.

20260 citations

HIV Research and Treatment

HIV/AIDS drug development and treatment

Immune Cell Function and Interaction

Hepatitis C virus research

Gastrointestinal motility and disorders

Influenza Virus Research Studies

Liver Diseases and Immunity

HIV/AIDS Research and Interventions

Helicobacter pylori-related gastroenterology studies

Gert De Hertogh Spaarne Gasthuis

542 works16,063 citationsh-index: 67

Perry Barrett New York University

292 works10,899 citationsh-index: 55

Jamal Tazi Centre National de la Recherche Scientifique

127 works8,504 citationsh-index: 47

Jacqueline Marvel Université Claude Bernard Lyon 1

182 works8,311 citationsh-index: 44

Paul Willems Maastricht University Medical Centre

240 works5,262 citationsh-index: 42

P1159 Pooled analysis of efficacy and safety of once-daily oral obefazimod in European patients from the ABTECT Phase 3, double-blind, placebo-controlled induction trials

F Scaldaferri,U Seidler,et al.

20260 citations

DOP102 Improvements in patient-reported fatigue among patients with moderately to severely active ulcerative colitis (UC) treated with obefazimod induction therapy: pooled results from the 8-week ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials

M C Dubinsky,S Danese,et al.

20260 citations

P0894 Impact of prior advanced therapy inadequate response by drug class on symptomatic improvement with obefazimod in patients with moderately to severely active ulcerative colitis: pooled analysis of ABTECT Phase 3 induction trials

S Danese,B E Sands,et al.

20260 citations

P0690 Impact of concomitant use of corticosteroids on efficacy and safety of obefazimod at week 8 of induction trials in patients with moderately to severely active ulcerative colitis: results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials

Xavier Treton,M C Dubinsky,et al.

20260 citations

DOP060 Impact of baseline disease extent on efficacy of obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from ABTECT-1 and ABTECT-2 phase 3 trials

S Heeren,Parambir S. Dulai,et al.

20260 citations